Skip to content

PHARMA-THUILLIES: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PHARMA-THUILLIES

BE 0563.416.085
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 compared with 2023filed annual accounts (NBB)
Net result for the year
€23,990
2023 · €55,074-€31,084
Equity
€252,701
2023 · €253,711-€1,010
Cash
€55,968
2023 · €37,008+€18,960
Balance sheet total
€331,960
2023 · €311,121+€20,839

Largest movements

2023 to 2024
Assets
  • Cash +€18,960

    up €18,960 (+51.2%), from €37,008 to €55,968

    mainly Tax, wage and social debts (+€27,968) and Net result for the year (+€23,990)

  • Intangible fixed assets -€12,863

    no longer reported in 2024 (was €12,863)

  • Stocks and contracts +€11,596

    up €11,596 (+13.5%), from €85,759 to €97,355

  • Receivables within one year +€3,339

    up €3,339 (+1.9%), from €173,452 to €176,791

    of which Trade receivables: +€4,644

Equity and liabilities
  • Current portion of long-term debt -€34,550

    no longer reported in 2024 (was €34,550)

  • Tax, wage and social debts +€27,968

    up €27,968 (+126%), from €22,184 to €50,152

    of which Taxes: +€26,604

  • Profit (loss) carried forward -€25,000

    down €25,000 (-10.5%), from €237,351 to €212,351

  • Reserves +€23,990

    up €23,990 (+1,290%), from €1,860 to €25,850

    of which Distributable reserves: +€23,990

  • Other debts +€17,500

    new in 2024: €17,500

Income statement
  • Gross operating margin -€37,861

    down €37,861 (-38.8%), from €97,510 to €59,649

  • Depreciation -€10,497

    down €10,497 (-44.5%), from €23,609 to €13,112

  • Taxes -€4,068

    down €4,068 (-18.3%), from €22,184 to €18,116

  • Financial charges -€1,231

    down €1,231 (-46.4%), from €2,654 to €1,423

  • Financial income +€1,102

    up €1,102 (+15.1%), from €7,273 to €8,375

From the 2023 result to the 2024 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2023 €55,074
Gross operating margin -€37,861
Depreciation +€10,497
Other operating charges +€423
Other operating items -€10,543
Financial income +€1,102
Financial charges +€1,231
Taxes +€4,068
Result 2024 €23,990
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2023 to 2024

Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€78,510
Investment +€0
Financing -€59,550
Cash 2023 €37,008
Net result for the year +€23,990
Depreciation +€13,112
Stocks and contracts -€11,596
Receivables within one year -€3,339
Deferred charges and accrued income -€56
Trade debts +€10,931
Tax, wage and social debts +€27,968
Other debts +€17,500
Investment in fixed assets (net) +€0
Current portion of long-term debt -€34,550
Contributions, distributions and other -€25,000
Cash 2024 €55,968
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2023 2024 Change %
Total assets 20/58 €311,121 €331,960 +€20,839 +6.7%
Fixed assets 21/28 €13,448 €336 -€13,112 -97.5%
Intangible fixed assets 21 €12,863 - -€12,863
Tangible fixed assets 22/27 €420 €171 -€249 -59.3%
Furniture and vehicles 24 €420 €171 -€249 -59.3%
Financial fixed assets 28 €165 €165 = 0.0%
Current assets 29/58 €297,673 €331,625 +€33,952 +11.4%
Stocks and contracts in progress 3 €85,759 €97,355 +€11,596 +13.5%
Stocks 30/36 €85,759 €97,355 +€11,596 +13.5%
Amounts receivable within one year 40/41 €173,452 €176,791 +€3,339 +1.9%
Trade receivables 40 €34,945 €39,589 +€4,644 +13.3%
Other amounts receivable 41 €138,507 €137,203 -€1,304 -0.9%
Cash at bank and in hand 54/58 €37,008 €55,968 +€18,960 +51.2%
Deferred charges and accrued income 490/1 €1,454 €1,510 +€56 +3.9%
Total equity and liabilities 10/49 €311,121 €331,960 +€20,839 +6.7%
Equity 10/15 €253,711 €252,701 -€1,010 -0.4%
Contributions 10/11 €14,500 €14,500 = 0.0%
Reserves 13 €1,860 €25,850 +€23,990 +1,290%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Distributable reserves 133 - €23,990 +€23,990
Profit (loss) carried forward 14 €237,351 €212,351 -€25,000 -10.5%
Amounts payable 17/49 €57,410 €79,259 +€21,849 +38.1%
Amounts payable within one year 42/48 €57,410 €79,259 +€21,849 +38.1%
Current portion of amounts payable after more than one year 42 €34,550 - -€34,550
Trade debts 44 €676 €11,607 +€10,931 +1,617%
Suppliers 440/4 €676 €11,607 +€10,931 +1,617%
Taxes, remuneration and social security 45 €22,184 €50,152 +€27,968 +126%
Taxes 450/3 €22,184 €48,788 +€26,604 +120%
Remuneration and social security 454/9 - €1,364 +€1,364
Other amounts payable 47/48 - €17,500 +€17,500
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €23,609 €13,112 -€10,497 -44.5%
Other operating charges 640/8 €1,262 €839 -€423 -33.5%
Non-recurring operating charges 66A - €10,543 +€10,543
Gross operating margin 9900 €97,510 €59,649 -€37,861 -38.8%
Operating profit (loss) 9901 €72,639 €35,155 -€37,484 -51.6%
Financial income 75/76B €7,273 €8,375 +€1,102 +15.1%
Recurring financial income 75 €7,273 €8,375 +€1,102 +15.1%
Financial charges 65/66B €2,654 €1,423 -€1,231 -46.4%
Recurring financial charges 65 €2,654 €1,423 -€1,231 -46.4%
Profit (loss) for the period before taxes 9903 €77,258 €42,107 -€35,151 -45.5%
Income taxes 67/77 €22,184 €18,116 -€4,068 -18.3%
Profit (loss) for the period 9904 €55,074 €23,990 -€31,084 -56.4%
Profit (loss) for the period to be appropriated 9905 €55,074 €23,990 -€31,084 -56.4%

Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.